LRRC32 (DS-1055 Biosimilar) Recombinant Monoclonal Antibody
-
貨號(hào):CSB-RA618886MB1HU
-
規(guī)格:¥83486
-
其他:
產(chǎn)品詳情
-
產(chǎn)品描述:LRRC32(DS-1055 Biosimilar Antibody)重組單克隆抗體是一種用于生命科學(xué)研究的重組蛋白工具。該產(chǎn)品通過基因工程技術(shù)制備,具有高度的結(jié)構(gòu)均一性和生物活性,為科研人員提供可靠的實(shí)驗(yàn)材料。 作為重組單克隆抗體,LRRC32(DS-1055 Biosimilar)具有高特異性和親和力,能夠精準(zhǔn)識(shí)別靶標(biāo)分子,適用于多種實(shí)驗(yàn)應(yīng)用,如、以及酶聯(lián)免疫吸附實(shí)驗(yàn)(ELISA)等。其重組表達(dá)體系確保了批次間的穩(wěn)定性,有助于提高實(shí)驗(yàn)結(jié)果的可重復(fù)性。 該抗體在研究中可用于探索LRRC32蛋白的生理功能、信號(hào)通路機(jī)制以及相關(guān)疾病的分子基礎(chǔ)。通過特異性結(jié)合LRRC32靶點(diǎn),研究人員能夠深入分析其在細(xì)胞增殖、分化、凋亡等生物學(xué)過程中的作用,為疾病的診斷與治療研究提供重要依據(jù)。 LRRC32(DS-1055 Biosimilar Antibody)重組單克隆抗體僅用于科研用途,為生命科學(xué)領(lǐng)域的基礎(chǔ)研究和應(yīng)用研究提供有力支持。其嚴(yán)格的生產(chǎn)工藝和質(zhì)量控制標(biāo)準(zhǔn),保證了產(chǎn)品的高純度和低內(nèi)毒素水平,滿足各類細(xì)胞實(shí)驗(yàn)和分子生物學(xué)研究的要求,助力科研人員在相關(guān)領(lǐng)域取得突破性進(jìn)展。
-
Uniprot No.:
-
基因名:
-
別名:DS 1055a research-grade biosimilar; DS 1055A research-grade biosimilar; DS-1055A research-grade biosimilar ;LRRC32 antibody; D11S833E antibody; Transforming growth factor beta activator LRRC32 antibody; Garpin antibody; Glycoprotein A repetitions predominant antibody; GARP antibody; Leucine-rich repeat-containing protein 32 antibody
-
反應(yīng)種屬:Human
-
免疫原:Recombinant Human LRRC32 protein
-
免疫原種屬:Homo sapiens (Human)
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Monoclonal
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:0.01M PBS,pH7.4
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用說明:Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method. -
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:3-4 weeks
-
用途:It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Associates specifically via disulfide bonds with the Latency-associated peptide (LAP), which is the regulatory chain of TGF-beta, and regulates integrin-dependent activation of TGF-beta. Able to outcompete LTBP1 for binding to LAP regulatory chain of TGF-beta. Controls activation of TGF-beta-1 (TGFB1) on the surface of activated regulatory T-cells (Tregs). Required for epithelial fusion during palate development by regulating activation of TGF-beta-3 (TGFB3).
-
基因功能參考文獻(xiàn):
- GARP is a surface molecule of regulatory T cells with roles in the regulatory function and TGF-beta releasing [review] PMID: 27095576
- Data show that the Treg activation marker GARP (glycoprotein A repetitions predominant) is expressed on primary melanoma. PMID: 27248166
- High GARP expression is associated with pancreatic cancer and liver metastases from colorectal cancer. PMID: 26885615
- study showed that stimulated, human B lymphocytes produce active TGF-beta1 from surface GARP/latent TGF-beta1 complexes with isotype switching to IgA production. PMID: 28607112
- GARP plays an important role in the pathogenesis of atopic dermatitis. PMID: 27884290
- CD4(+) CD25(+) GARP(+) Treg cells are defective in dilated cardiomyopathy patients and GARP seems to be a better molecular definition of the regulatory phenotype. PMID: 28207945
- these results define the oncogenic effects of the GARP-TGFbeta axis in the tumor microenvironment PMID: 27913437
- LRRC32 expression is significantly upregulated in human masticatory mucosa during wound healing PMID: 28005267
- GARP deficiency leads to accumulation of sphingolipid synthesis intermediates, changes in sterol distribution, and lysosomal dysfunction. PMID: 26357016
- since GARP functions as a transporter of transforming growth factor beta (TGFbeta), a cytokine with broad pleiotropic traits, GARP transcriptional attenuation by alternative promoters might provide a mechanism regulating peripheral TGFb PMID: 26584734
- GARP is regulated by miRNAs and controls latent TGF-beta1 production by human regulatory T cells. PMID: 24098777
- we investigated in detail miR-142-3 pregulation of GARP expression in regulatory CD25(+) CD4 T cells PMID: 23650616
- Findings support the idea that GARP is a new latent TGFbeta-binding protein that regulates the bioavailability of TGFbeta and provides a cell surface platform for alphaV integrin-dependent TGFbeta activation. PMID: 22278742
- There are 2 independent signals, one in C11orf30 and the other in LRRC32, that are strongly associated with serum IgE levels. C11orf30-LRRC32 region may represent a common locus for atopic diseases via pathways involved in regulation of serum IgE levels PMID: 22070912
- GARP is a key receptor controlling FOXP3 in T(reg) cells following T-cell activation in a positive feedback loop assisted by LGALS3 and LGMN PMID: 19453521
- the processing and expression of LRRC32 PMID: 21615933
- on chromosome 11q13.5 near the leucine-rich repeat containing 32 gene (LRRC32, also known as GARP) associated with asthma risk PMID: 21907864
- GARP is a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression PMID: 18628982
- Platelets and activated Tregs co-express latent TGF-beta and GARP on their membranes. PMID: 19651619
- Expression of GARP on activated regulatory T cells correlates with their suppressive capacity. PMID: 19666573
- Data show that latent TGF-beta, i.e. both LAP and mature TGF-beta, binds to GARP, which is present on the surface of stimulated Treg clones but not on Th clones. PMID: 19750484
顯示更多
收起更多
-
亞細(xì)胞定位:Cell membrane; Single-pass type I membrane protein. Cell surface.
-
組織特異性:Preferentially expressed in regulatory T-cells (Tregs).
-
數(shù)據(jù)庫鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















